Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial.

Abstract

A double-blind, randomized, multicentre trial was carried out in 47 psychotic patients to evaluate the efficacy of oral treatment with loxapine compared with perphenazine. In total, 22 patients were included in diagnostic Group I (cases of acute schizophrenia and psychogenic (reactive) psychoses). The average maximum daily dose was 60.0 mg in the loxapine… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.